Omega Healthcare Investors (NYSE:OHI) Given New $43.00 Price Target at Royal Bank of Canada

Omega Healthcare Investors (NYSE:OHI) had its price target boosted by Royal Bank of Canada from $39.00 to $43.00 in a research note released on Monday,Benzinga reports. Royal Bank of Canada currently has a sector perform rating on the real estate investment trust’s stock.

A number of other equities research analysts have also commented on the company. Mizuho lowered Omega Healthcare Investors from an “outperform” rating to a “neutral” rating and raised their price target for the stock from $34.00 to $35.00 in a research report on Thursday, July 25th. Berenberg Bank began coverage on Omega Healthcare Investors in a research report on Friday, October 18th. They set a “buy” rating and a $45.00 price target on the stock. Scotiabank increased their price objective on Omega Healthcare Investors from $33.00 to $39.00 and gave the stock a “sector perform” rating in a report on Monday, August 26th. BNP Paribas upgraded Omega Healthcare Investors from a “neutral” rating to an “outperform” rating and set a $49.00 price objective for the company in a report on Thursday, October 31st. Finally, BMO Capital Markets increased their price objective on Omega Healthcare Investors from $44.00 to $45.00 and gave the stock a “market perform” rating in a report on Monday, October 7th. Seven investment analysts have rated the stock with a hold rating and five have issued a buy rating to the company’s stock. According to MarketBeat, Omega Healthcare Investors currently has an average rating of “Hold” and a consensus price target of $40.00.

Omega Healthcare Investors Trading Up 0.1 %

NYSE OHI opened at $41.39 on Monday. The firm has a market cap of $11.17 billion, a P/E ratio of 30.43, a P/E/G ratio of 1.33 and a beta of 0.99. The company has a debt-to-equity ratio of 1.10, a current ratio of 6.48 and a quick ratio of 6.48. The stock’s 50-day moving average is $40.59 and its 200-day moving average is $36.40. Omega Healthcare Investors has a one year low of $27.53 and a one year high of $44.42.

Omega Healthcare Investors Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, November 15th. Shareholders of record on Monday, November 4th will be paid a $0.67 dividend. The ex-dividend date of this dividend is Monday, November 4th. This represents a $2.68 dividend on an annualized basis and a yield of 6.47%. Omega Healthcare Investors’s dividend payout ratio is 197.06%.

Insider Buying and Selling at Omega Healthcare Investors

In other news, CFO Robert O. Stephenson sold 22,542 shares of Omega Healthcare Investors stock in a transaction that occurred on Friday, September 27th. The stock was sold at an average price of $40.19, for a total transaction of $905,962.98. Following the completion of the transaction, the chief financial officer now directly owns 183,076 shares in the company, valued at approximately $7,357,824.44. The trade was a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. In other news, COO Daniel J. Booth sold 56,725 shares of Omega Healthcare Investors stock in a transaction that occurred on Friday, September 27th. The stock was sold at an average price of $40.25, for a total transaction of $2,283,181.25. Following the completion of the transaction, the chief operating officer now directly owns 100,000 shares in the company, valued at approximately $4,025,000. The trade was a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CFO Robert O. Stephenson sold 22,542 shares of Omega Healthcare Investors stock in a transaction that occurred on Friday, September 27th. The stock was sold at an average price of $40.19, for a total value of $905,962.98. Following the sale, the chief financial officer now directly owns 183,076 shares of the company’s stock, valued at approximately $7,357,824.44. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 1.37% of the company’s stock.

Institutional Trading of Omega Healthcare Investors

Several hedge funds have recently added to or reduced their stakes in the company. Cypress Capital Group acquired a new stake in Omega Healthcare Investors during the 3rd quarter worth approximately $225,000. Advisors Asset Management Inc. lifted its holdings in Omega Healthcare Investors by 2.6% during the 3rd quarter. Advisors Asset Management Inc. now owns 118,273 shares of the real estate investment trust’s stock worth $4,814,000 after purchasing an additional 3,041 shares during the last quarter. Pathstone Holdings LLC lifted its holdings in Omega Healthcare Investors by 23.9% during the 3rd quarter. Pathstone Holdings LLC now owns 32,112 shares of the real estate investment trust’s stock worth $1,307,000 after purchasing an additional 6,199 shares during the last quarter. Quest Partners LLC acquired a new stake in Omega Healthcare Investors during the 3rd quarter worth approximately $514,000. Finally, Thrivent Financial for Lutherans lifted its holdings in Omega Healthcare Investors by 1.5% during the 3rd quarter. Thrivent Financial for Lutherans now owns 60,575 shares of the real estate investment trust’s stock worth $2,465,000 after purchasing an additional 871 shares during the last quarter. 65.25% of the stock is owned by institutional investors and hedge funds.

Omega Healthcare Investors Company Profile

Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.